Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:SLGC

Standard BioTools (SLGC) Stock Price, News & Analysis

Standard BioTools logo

About Standard BioTools Stock (NASDAQ:SLGC)

Advanced Chart

Key Stats

Today's Range
$1.93
$2.31
50-Day Range
$2.10
$2.83
52-Week Range
$1.73
$3.79
Volume
33.91 million shs
Average Volume
10.83 million shs
Market Capitalization
$394.95 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for its cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples. The company's SOMAmers/SomaScan technology enables researchers to analyze various biological samples for protein biomarker signatures, which are utilized in drug discovery and development. Its SomaScan's biomarker discoveries use in diagnostic applications for various diseases, including cardiovascular and metabolic disease, nonalcoholic steatohepatitis, wellness, and others. The company also provides SomaSignal, a laboratory-developed test. It serves pharmaceutical and biotechnology companies, and academic and government research institutions. The company has a collaboration agreement with Illumina Cambridge, Ltd for the development of co-branded NGS-based proteomic distributable kits. The company was founded in 1999 and is headquartered in Boulder, Colorado.

Receive SLGC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Standard BioTools and its competitors with MarketBeat's FREE daily newsletter.

SLGC Stock News Headlines

Do You Believe In President Trump? Answer This 1 Question
They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to Trump’s economic plan. But now there’s a way to protect your retirement without backing down. This free 2025 Wealth Protection Guide reveals how you can use a legal IRS loophole—nicknamed “Piggy Bank”—to shield your savings.
Standard BioTools Inc. Reports Q3 2024 Financial Performance
See More Headlines

SLGC Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Standard BioTools investors own include Digital Turbine (APPS), CrowdStrike (CRWD), SoFi Technologies (SOFI), Vuzix (VUZI) and Okta (OKTA).

Company Calendar

Today
5/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Commercial physical research
Sub-Industry
N/A
Current Symbol
NASDAQ:SLGC
Fax
N/A
Employees
451
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$109.16 million
Net Margins
-159.54%
Pretax Margin
-159.08%

Debt

Sales & Book Value

Annual Sales
$97.67 million
Price / Cash Flow
N/A
Book Value
$3.00 per share
Price / Book
0.70

Miscellaneous

Free Float
160,049,000
Market Cap
$394.95 million
Optionable
Optionable
Beta
1.64
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:SLGC) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners